Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
May 27, 2008

Advanced BioScience Laboratories Gains Rights to Inovio’s Electroporation Delivery Technology

  • Inovio Biomedical entered into a license agreement with Advanced BioScience Laboratories (ABL) so that ABL may provide advanced electroporation delivery of DNA vaccines for its research uses. The license will permit ABL to conduct certain internal research on DNA vaccines and to offer electroporation delivery of DNA vaccines as a service for its research customers. Inovio will receive a royalty on such services.
  • Finally! A cure for the Biotech News Blues.

  • Join 110,000 colleagues who rely on GEN Highlights for breaking news and exclusive articles shaping today’s life science tools and technologies.

  • Oops! Please type your email in the following format: yourname@example.com An error has occurred. Please contact Customer Service at contactGEN@genengnews.com
  • You’re all set! Thank you for subscribing to GEN Highlights.